Sotair for Manual Resuscitation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test different methods of manual ventilation, the process of assisting breathing with a hand-held bag. The research will evaluate the effectiveness of three setups in scenarios simulating various lung conditions. Participants will assess a standard resuscitator bag, a flow-limiting bag, and a flow rate limiting device combined with a standard bag. Ideal participants are adults with basic life support certification who can commit to a 10-hour session. As an unphased trial, this study allows participants to contribute to innovative research that could enhance emergency medical care techniques.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this device is safe for manual resuscitation?
Research has shown that the Sotair device, when used with manual resuscitators, maintains safe air flow rates. It controls the air entering the lungs, preventing issues like over-inflation. Studies indicate it effectively limits inhaled air, reducing high lung pressure.
The FDA has approved the device for use with manual resuscitators in patients unable to breathe independently. This approval confirms its safety in specific situations.
No specific data on negative effects appear in the sources, but the Sotair device's approval for similar uses offers some reassurance about its safety.12345Why are researchers excited about this trial?
Researchers are excited about the Sotair device because it could enhance manual resuscitation techniques. Unlike traditional methods using just an Ambu bag, the Sotair device is integrated into the process to potentially improve ventilation efficiency, particularly with patients who have low lung compliance. This innovation could lead to better patient outcomes by offering more consistent ventilation support. By investigating the performance of this new device in different lung compliance scenarios, researchers hope to discover improved strategies for manual ventilation, ultimately benefiting emergency and critical care protocols.
What evidence suggests that this trial's treatments could be effective?
Research has shown that the Sotair device, which participants in this trial may receive, could improve manual ventilation. Studies indicate it helps maintain important measures like peak airway pressure and tidal volume (the amount of air moving in and out of the lungs) near ideal levels. This improvement could make manual ventilation safer and more effective, especially compared to using a bag-valve-mask (BVM) alone. The FDA has approved the device for limiting airflow, which helps prevent excessive pressure that could harm the lungs. These features suggest that Sotair could become a new standard in emergency ventilation care.678910
Who Is on the Research Team?
Mark Brady, MD
Principal Investigator
Brown Physicians, Inc.
Are You a Good Fit for This Trial?
This trial is for individuals who are at least 18 years old with a current basic life support (BLS) certification. Participants must be available to complete the full 10-hour protocol. Those with medical or respiratory therapy school training, or who cannot commit to the full duration, are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Simulation
Participants undergo simulated lung scenarios using various manual resuscitator bags and devices
Follow-up
Participants are monitored for safety and effectiveness after simulation
What Are the Treatments Tested in This Trial?
Interventions
- Prolonged Manual Ventilation Simulation
Trial Overview
The study tests three methods of manual resuscitation: using a standard manual resuscitator bag, a flow limiting resuscitator bag, and an FDA approved flow rate limiting device paired with a standard manual resuscitator in simulated lung scenarios.
How Is the Trial Designed?
6
Treatment groups
Active Control
Manual ventilation with Ambu bag and low lung compliance.
Manual ventilation with smart bag and normal lung compliance.
Manual ventilation with Ambu bag and Sotair device with low lung compliance.
Manual ventilation with Ambu bag and normal lung compliance.
Manual ventilation with smart bag and low lung compliance.
Manual ventilation with Ambu bag and Sotair device with normal lung compliance.
Find a Clinic Near You
Who Is Running the Clinical Trial?
SafeBVM
Lead Sponsor
United States Department of Defense
Collaborator
Published Research Related to This Trial
Citations
NCT06805838 | Prolonged Manual Ventilation Simulation
Adult Sotair® device has FDA clearance as a Class II device through the 510(k) pathway (K212905) for the intended use of "Flow-limiting, safe, and optimal ...
Project Details - NIH RePORTER
This innovation positions Sotair as the new gold standard for manual ventilation, enabling safer and more effective care even in resource- limited emergency ...
Device in Manual Ventilation of Different Lung Compliances
Results: We found that the SotairTM device helped maintain PIP and TV closer to mechanical ventilator baseline levels than BVM only ventilation ...
Sotair® Literature & Ongoing Clinical Trials
This study demonstrates that SafeBVM's Sotair flow-limiting device significantly improves manual ventilation control, ensuring peak airway pressures remain ...
Non-inferiority Trial Between Sotair® Device Attached to ...
Effective respiratory ventilation is achieved by moving the right amount of air in and out of the lungs while keeping the pressures at a safe ...
Sotair
The valve prevents flow rates of air from exceeding 55 LPM during manual ventilation, ensuring that air delivery stays within safe limits. Flow control helps ...
K212905 - Sara Toyloy - accessdata.fda.gov
The Sotairm device is intended for use with a manual resuscitator with air-tight connections, in non-breathing patients that require flow ...
Manual Ventilation Performance With Safety Device in ...
A new flow-limiting device (Sotair by SafeBVM, Boston, Massachusetts) limits inspiratory flow during manual ventilation, thus minimizing peak inspiratory ...
9.
rescue-essentials.com
rescue-essentials.com/content/Sotair%20Literature%20ALL.pdf?srsltid=AfmBOor6HS024oa4sTuQrGmOa0Cm4nI1bGql0gjei0OWEPgKWyZ-rYGGSotair Literature ALL.pdf
SafeBVM Corp. is developing the universally compatible Sotair Device to prevent gastric insufflation during manual ventilation with the. BVM. In regular use, ...
Feasibility of manual ventilation replacing mechanical ...
The mean (±SD) tidal volume with bag only was 563.9±128.8 mL and with the safety device 536.1±80.9 mL (p<0.0001). The mean peak inspiratory pressure with bag ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.